Review Article
Pathogenesis and treatment of parenteral nutrition-associated liver disease

https://doi.org/10.1016/S1499-3872(12)60229-XGet rights and content

Background

Parenteral nutrition-associated liver disease (PNALD) has been common in patients who require long-term parenteral nutrition. PNALD develops in 40%–60% of infants on long-term parenteral nutrition compared with 15%–40% of adults on home parenteral nutrition for intestinal failure. The pathogenesis of PNALD is multifactorial and remains unclear. There is no specific treatment. Management strategies for its prevention and treatment depend on an understanding of many risk factors. This review aims to provide an update on the pathogenesis and treatment of this disease.

Data Sources

A literature search was performed on the MEDLINE and Web of Science databases for articles published up to October 2011, using the keywords: parenteral nutrition associated liver disease, intestinal failure associated liver disease, lipid emulsions and fish oil. The available data reported in the relevant literatures were analyzed.

Results

The literature search provided a huge amount of evidence about the pathogenesis and management strategies on PNALD. Currently, lack of enteral feeding, extended duration of parenteral nutrition, recurrent sepsis, and nutrient deficiency or excess may play important roles in the pathogenesis of PNALD. Recent studies found that phytosterols, present as contaminants in soy-based lipid emulsions, are also an important factor in the pathogenesis. Moreover, the treatment of PNALD is discussed.

Conclusions

The use of lipid emulsions, phytosterols in particular, is associated with PNALD. Management strategies for the prevention and treatment of PNALD include consideration of early enteral feeding, the use of specialized lipid emulsions such as fish oil emulsions, and isolated small bowel or combined liver and small bowel transplantation. A greater understanding of the pathogenesis of PNALD has led to promising interventions to prevent and treat this condition. Future work should aim to better understand the mechanisms of PNALD and the long-term outcomes of its treatment.

References (85)

  • PT Clayton et al.

    Phytosterolemia in children with parenteral nutrition-associated cholestatic liver disease

    Gastroenterology

    (1993)
  • CJ Sinal et al.

    Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis

    Cell

    (2000)
  • JJ Eloranta et al.

    Coordinate transcriptional regulation of bile acid homeostasis and drug metabolism

    Arch Biochem Biophys

    (2005)
  • C Degott et al.

    Liver phospholipidosis induced by parenteral nutrition: histologic, histochemical, and ultrastructural investigations

    Gastroenterology

    (1988)
  • TJ Richardson et al.

    Essential fatty acid deficiency in four adult patients during total parenteral nutrition

    Am J Clin Nutr

    (1975)
  • DD Black et al.

    The effect of short-term total parenteral nutrition on hepatic function in the human neonate: a prospective randomized study demonstrating alteration of hepatic canalicular function

    J Pediatr

    (1981)
  • AL Buchman et al.

    Low plasma free choline is prevalent in patients receiving long term parenteral nutrition and is associated with hepatic aminotransferase abnormalities

    Clin Nutr

    (1993)
  • RK Chawla et al.

    Plasma concentrations of transsulfuration pathway products during nasoenteral and intravenous hyperalimentation of malnourished patients

    Am J Clin Nutr

    (1985)
  • AL Buchman et al.

    Choline deficiency: a cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation

    Hepatology

    (1995)
  • DP O'Brien et al.

    Intestinal permeability and bacterial translocation are uncoupled after small bowel resection

    J Pediatr Surg

    (2002)
  • RL Moss et al.

    New approaches to understanding the etiology and treatment of total parenteral nutrition-associated cholestasis

    Semin Pediatr Surg

    (1999)
  • YH Paik et al.

    Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells

    Hepatology

    (2003)
  • GR Greenberg et al.

    Effect of total parenteral nutrition on gut hormone release in humans

    Gastroenterology

    (1981)
  • ZG Ren et al.

    Protective effect of probiotics on intestinal barrier function in malnourished rats after liver transplantation

    Hepatobiliary Pancreat Dis Int

    (2011)
  • MI Spagnuolo et al.

    Ursodeoxycholic acid for treatment of cholestasis in children on long-term total parenteral nutrition: a pilot study

    Gastroenterology

    (1996)
  • DA Kelly

    Preventing parenteral nutrition liver disease

    Early Hum Dev

    (2010)
  • L Pironi et al.

    Fish oil-based emulsion for the treatment of parenteral nutrition associated liver disease in an adult patient

    e-SPEN Eur E J Clin Nutr Metab

    (2010)
  • Z Xu et al.

    Effect of omega-3 polyunsaturated fatty acids to reverse biopsy-proven parenteral nutrition-associated liver disease in adults

    Clin Nutr

    (2012)
  • HD Le et al.

    Parenteral fish-oil-based lipid emulsion improves fatty acid profiles and lipids in parenteral nutrition-dependent children

    Am J Clin Nutr

    (2011)
  • Y Wang et al.

    Protective effect of parenteral glutamine supplementation on hepatic function in very low birth weight infants

    Clin Nutr

    (2010)
  • J Wu et al.

    Glutamine attenuates TPN-associated liver injury in infant rabbits

    Eur J Pediatr

    (2007)
  • SC Fitzgibbons et al.

    Relationship between biopsy-proven parenteralnutrition-associated liver fibrosis and biochemical cholestasis in children with short bowel syndrome

    J Pediatr Surg

    (2010)
  • A Lauro et al.

    Recovery from liver dysfunction after adult isolated intestinal transplantation without liver grafting

    Transplant Proc

    (2006)
  • M Hallikainen et al.

    Effect of parenteral serum plant sterols on liver enzymes and cholesterol metabolism in a patient with short bowel syndrome

    Nutr Clin Pract

    (2008)
  • BA Carter et al.

    Stigmasterol, a soy lipid-derived phytosterol, is an antagonist of the bile acid nuclear receptor FXR

    Pediatr Res

    (2007)
  • BA Carter et al.

    Mechanisms of disease: update on the molecular etiology and fundamentals of parenteral nutrition associated cholestasis

    Nat Clin Pract Gastroenterol Hepatol

    (2007)
  • AL Buchman et al.

    Parenteral nutrition-associated liver disease and the role for isolated intestine and intestine/liver transplantation

    Hepatology

    (2006)
  • VJ Kumpf

    Parenteral nutrition-associated liver disease in adult and pediatric patients

    Nutr Clin Pract

    (2006)
  • O Goulet et al.

    Some new insights in intestinal failure-associated liver disease

    Curr Opin Organ Transplant

    (2009)
  • A Wiles et al.

    Recent advances in the management of intestinal failure-associated liver disease

    Curr Opin Clin Nutr Metab Care

    (2009)
  • J Slicker et al.

    Pediatric parenteral nutrition: putting the microscope on macronutrients and micronutrients

    Nutr Clin Pract

    (2009)
  • D Duro et al.

    Risk factors for parenteral nutrition–associated liver disease following surgical therapy for necrotizing enterocolitis: A Glaser Pediatric Research Network Study

    J Pediatr Gastroenterol Nutr

    (2011)
  • Cited by (80)

    • Nutritional Considerations in the Hospital Setting

      2021, Gastroenterology Clinics of North America
      Citation Excerpt :

      For those unable to meet these goals spontaneously, EN is favored over PN because it helps to maintain gut integrity, which has possible implications in pathogenesis of alcoholic hepatitis.49 PN should generally be avoided in these patients given its inherent risks as well as its pathogenesis in liver disease.50 Other key practical nutritional measures for hospitalized patients with alcoholic hepatitis are to address common vitamin and micronutrient deficiencies (especially B vitamins, thiamine, and zinc), avoid prolonged periods of fasting and foods that make early satiety worse (high fiber), provide frequent snacks, especially at night time and in morning (to decrease gluconeogenesis/breakdown of protein), and consider feeding tubes in those unable to eat on their own violation.44

    View all citing articles on Scopus
    View full text